Patients with very large intrahepatic cholangiocarcinoma experienced improved outcomes when targeted, high-dose radiation was added to chemotherapy
PHILADELPHIA – Patients with supermassive intrahepatic cholangiocarcinoma (ICC) benefited from ablative radiation therapy, a treatment that is typically used to treat non-supermassive ICC, according to a study published in Clinical Cancer Research, a journal of the American Association for Cancer Research (AACR).
Cholangiocarcinoma is a rare cancer of the bile ducts, and the intrahepatic variant—which accounts for about 10% of cases—forms in the bile ducts within the liver.
While some patients with ICC can undergo curative-intent surgery, most patients have tumors that are unresectable due to their size or stage of progression.
“For patients with…